Evidence map›Paper›PMID 39731539›Full record

ArticleBiochemistry2025

Chemoenzymatic Formation of Oxa-Terpenoids by Sesqui- and Diterpene Synthase-Mediated Biotransformations with 9-Oxy-FPP Ether Derivatives.

Henry Struwe, Trang Nguyen, Svenja Schwörer, Jörn Droste, Hanke Spinck, Andreas Kirschning

Abstract read
In one paragraph

Article in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Henry StruweInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.
Trang NguyenInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.
Svenja SchwörerInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.
Jörn DrosteInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.
Hanke SpinckInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.
Andreas KirschningInstitute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 1B, Hannover 30167, Germany.ORCID 0000-0001-5431-6930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Farnesyl pyrophosphate derivatives bearing an additional oxygen atom at position 5 proved to be very suitable for expanding the substrate promiscuity of sesquiterpene synthases (STSs) and the formation of new oxygenated terpenoids. Insertion of an oxygen atom in position 9, however, caused larger restraints that led to restricted acceptance by STSs. In order to reduce some of the proposed restrictions, two FPP-ether derivatives with altered substitution pattern around the terminal olefinic double bond were designed. These showed improved promiscuity toward different STSs. Four new cyclized terpenoids with an embedded ether group were isolated and characterized. In the case of two cyclic enol ethers, also the corresponding "hydrolysis" products, linear hydroxyaldehydes, were isolated. Interestingly, all cyclization products originate from an initial 1 → 12 cyclization unprecedented when native farnesyl pyrophosphate serves as a substrate. We found that the most suitable FPP derivative with an additional oxygen at position 9 does not carry any methyl group on the terminal alkene, which likely reduces steric congestion when the preferred conformation for cyclization is adopted in the active site.

Indexed as

Alkyl and Aryl TransferasesPolyisoprenyl PhosphatesSesquiterpenesTerpenesBiotransformationCyclizationSubstrate SpecificityAlkyl and Aryl Transferasesfarnesyl pyrophosphatePolyisoprenyl PhosphatesSesquiterpenesTerpenesterpene synthase

Identifiers

PMID39731539
PMCPMC11756643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.